Axt Inc

This advisory proposal requests stockholders to approve, on a non-binding basis, the compensation paid to the Named Executive Officers as disclosed in the proxy statement, including the Compensation Discussion and Analysis and related tables. Management frames the program as pay-for-performance, combining base salary, performance-weighted annual bonuses and long-term restricted stock awards (50% of annual equity award tied to a financial metric with multi‑year vesting). The Board and Compensation Committee argue the program targets the 50th percentile of a defined peer group, uses an independent compensation consultant, applies clawback and anti-hedging policies, and ties a significant portion of pay to measurable corporate financial targets. The Company emphasizes recent adjustments (salary increases effective November 1, 2025, conversion of a Q1 cash bonus into RSAs, and certification of 2025 revenue results leading to heightened equity payout) as evidence of alignment between pay and performance. The vote is advisory and non-binding, but the Board commits to consider substantial negative votes and to engage with stockholders and possibly adjust compensation practices in response. Because the proposal is non-routine, broker non-votes do not affect its outcome, requiring a majority of votes cast to approve. Investors should weigh the demonstrated link between recent financial results and awards, the use of performance metrics with specified thresholds and caps, and potential dilution from equity grants when evaluating alignment. The Board’s recommendation FOR reflects confidence that the compensation framework advances retention and incentives that promote long‑term stockholder value while maintaining governance safeguards.

This management proposal asks stockholders to approve an amendment to the Company’s Restated Certificate of Incorporation to increase authorized common shares from 70 million to 120 million. Management argues the change provides corporate flexibility to issue equity for capital raises, strategic transactions (including acquisitions or collaborations), and employee equity incentives without seeking additional shareholder approval. The filing discloses there are approximately 11.2 million unreserved authorized shares as of the record date and that no definitive agreements currently exist to issue the additional shares; management emphasizes the increase is precautionary to enable opportunistic financings and to support recruitment/retention. The Board notes the issuance of additional shares would dilute existing shareholders’ percentage ownership, earnings per share and book value per share and cautions the amendment could potentially be used defensively in an unsolicited takeover scenario, though management states that dilution is not the purpose. Approval requires a majority of votes cast; the Board recommends FOR to maintain operational and strategic flexibility. Investors evaluating the proposal should assess the company’s near-term capital needs (including recent $100 million secondary offering), the existing reserve for awards and options, potential dilution under various issuance scenarios, and corporate governance safeguards against opportunistic issuance. The proposal’s practical effect depends on subsequent Board decisions about if, when, and how many of the newly authorized shares would actually be issued, so shareholders should consider requesting disclosure or limits (e.g., pre-emptive rights or issuer share-issuance policies) if they have concerns about dilution or takeover defense.

This management proposal asks shareholders to authorize the proxies to adjourn the annual meeting if, in the Board’s view, additional solicitation is necessary to obtain approval for Proposal 4 (the authorized‑shares amendment). Management frames the adjournment as a practical tool to allow more time to solicit votes, distribute supplemental disclosures if needed, and revisit votes without reopening the entire meeting process. The Board argues that being able to adjourn and continue solicitation is in stockholders’ interest because it may enable approval of a proposal the Board believes is important for strategic flexibility; however, approval could also allow management to delay a substantive shareholder decision while seeking to change votes. The vote is presented as separate from the underlying proposals so shareholders can approve other proposals while opposing adjournment. The Board recommends FOR, asserting that additional time to solicit is appropriate when there are insufficient votes for the Amendment Proposal. Investors should evaluate the governance implications of granting adjournment authority, including potential for management to use adjournment strategically versus legitimate need to complete informed voting, and may wish to consider whether the Company has committed to disclose any new materials distributed during an adjourned solicitation period. The practical impact of the approval depends on whether Proposal 4 initially fails and whether the Board uses the adjournment power to materially alter the solicitation or disclosure approach.